中文版
js_thumb bannerPic
/
/
Industry News
2018
03-28
小黑点

2018 two sessions of the pharmaceutical industry report

2018 is the year of national leaders' re-election and the first year to implement the spirit of the 19th CPC National Congress. In the past five years, what have been achieved in China's medical and health reform? What are the priorities of the government's work on medical and health reform in 2018? What are the hot topics of the two sessions that deserve attention? To this end, we have compiled the government work report issued during the two sessions , As well as suggestions from the representatives of the two associations, try to answer the above questions.try to answer the above questions.
查看详情
2018
03-28
小黑点

Targeted drug inventory of thirteen lung cancers already on the market

Iressa is the first generation of EGFR-TKI. China's approved indication is to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) with previous chemotherapy.
查看详情
Previous page
1
Search
Search

Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou
Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing
Contact number:
+86-10-80497001
Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province
Contact number:
+86-513-80562882(Administration & Human Resources)

                            +86-512-6515-8191(Marketing & Sales)
Company email: sales@hongweitest.com

Macro micro-test

WeChat

Copyright © 2021 Jiangsu Macro & Micro-Test Med-Tech Co.,Ltd.苏ICP备18057655号 苏公网安备 32062302000215号 Power by:300.cn
Suspended
返回顶部